What's new

PSUSA/00002492/202409

PSUSA/00002492/202409

May 19, 2025 - 17:35
 0
PSUSA/00002492/202409
PSUSA/00002492/202409
Read More

Tags:

Previous Article

STAT+: CRISPR pioneer Prime Medicine switches CEO and lays off quarter of its staff

Next Article

Space Force FORGEing ahead with missile warning ground system

Related Posts

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Medicine shortage communication (MSC): Fiasp PumpCart a...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0